IONS: Ionis Pharmaceuticals, Inc.
About
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Current Value
$33.851 Year Return
Current Value
$33.851 Year Return
Key Details
Market Cap
$5.33B
P/E Ratio
-13.81
1Y Stock Return
-31.18%
1Y Revenue Growth
30.63%
Dividend Yield
0.00%
Price to Book
8.0
Strategies that include IONS
Stock's related to IONS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ALNY | 47.43% | $30.22B | +43.13% | 0.00% |
| PGEN | 43.57% | $228.91M | -28.00% | 0.00% |
| ARWR | 38.37% | $2.31B | -34.44% | 0.00% |
| IDYA | 35.98% | $2.24B | -15.21% | 0.00% |
| RCKT | 33.79% | $1.20B | -39.83% | 0.00% |
| ARGX | 33.30% | $34.68B | +17.58% | 0.00% |
| BMRN | 32.45% | $11.81B | -29.63% | 0.00% |
| DNLI | 31.59% | $3.50B | +33.66% | 0.00% |
| BEAM | 31.53% | $2.09B | -9.52% | 0.00% |
| DMRC | 31.27% | $694.39M | -2.06% | 0.00% |
| PRTA | 30.79% | $756.01M | -56.52% | 0.00% |
| UTHR | 29.99% | $16.10B | +56.54% | 0.00% |
| RARE | 29.98% | $4.17B | +16.19% | 0.00% |
| FUN | 29.96% | $4.60B | -16.51% | 0.00% |
| DYN | 29.42% | $3.02B | +182.40% | 0.00% |
| CRSP | 29.39% | $4.01B | -30.49% | 0.00% |
| SNDR | 29.20% | $5.41B | +35.80% | 1.22% |
| PLRX | 29.00% | $778.32M | -9.55% | 0.00% |
| CRNX | 28.96% | $5.12B | +84.27% | 0.00% |
| AGIO | 28.96% | $3.10B | +148.79% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SHEN | 0.02% | $698.36M | -44.66% | 0.79% |
| QXO | 0.03% | $6.51B | -35.95% | 0.00% |
| FROG | 0.05% | $3.34B | +11.67% | 0.00% |
| GYRE | -0.09% | $1.21B | +1.49% | 0.00% |
| OBDE | 0.10% | $1.82B | -2.27% | 4.76% |
| MKC | 0.13% | $20.21B | +15.19% | 2.23% |
| KR | -0.13% | $42.03B | +35.08% | 2.11% |
| CRBG | -0.14% | $17.31B | +52.15% | 3.02% |
| ORCL | -0.21% | $523.45B | +62.73% | 0.84% |
| IRBT | 0.23% | $220.33M | -75.58% | 0.00% |
| IMNN | -0.31% | $10.02M | -22.89% | 0.00% |
| NOC | -0.32% | $71.54B | +4.23% | 1.60% |
| HEAR | -0.32% | $300.79M | +44.04% | 0.00% |
| DXYZ | -0.33% | - | - | 0.00% |
| SJM | -0.37% | $11.91B | -0.25% | 3.82% |
| SCI | 0.42% | $12.43B | +42.31% | 1.39% |
| JMIA | 0.44% | $380.31M | +30.53% | 0.00% |
| VRN | -0.44% | $3.23B | -25.43% | 6.21% |
| PDD | -0.46% | $163.43B | +0.29% | 0.00% |
| AMED | -0.47% | $2.95B | -3.95% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HUSA | -13.93% | $16.69M | -11.56% | 0.00% |
| MNR | -10.39% | $1.66B | -10.71% | 15.90% |
| CHD | -9.78% | $27.18B | +19.50% | 1.03% |
| SOLV | -9.14% | $11.58B | -16.19% | 0.00% |
| CBOE | -9.03% | $21.46B | +15.84% | 1.11% |
| MNOV | -8.67% | $93.19M | +2.15% | 0.00% |
| CB | -8.29% | $114.43B | +26.00% | 1.24% |
| CRVO | -8.18% | $83.20M | +2.86% | 0.00% |
| LFVN | -7.83% | $169.84M | +130.61% | 1.10% |
| PRPO | -7.53% | $9.10M | -13.65% | 0.00% |
| PEP | -7.45% | $215.02B | -6.60% | 3.35% |
| CVS | -7.23% | $70.18B | -18.08% | 4.72% |
| NTZ | -7.03% | $47.64M | -30.94% | 0.00% |
| ZCMD | -6.81% | $2.80M | -88.67% | 0.00% |
| LITB | -6.69% | $35.48M | -75.45% | 0.00% |
| CME | -6.43% | $82.76B | +9.21% | 1.98% |
| SCKT | -6.41% | $10.88M | +15.32% | 0.00% |
| NNVC | -6.07% | $19.66M | +25.69% | 0.00% |
| SSSS | -6.01% | - | - | 0.00% |
| KGS | -5.64% | $3.37B | +110.22% | 4.11% |
ETF's related to IONS
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBB | 47.09% | $6.66B | 0.45% |
| FBT | 46.49% | $1.11B | 0.56% |
| XBI | 45.69% | $6.58B | 0.35% |
| PBE | 45.37% | $258.53M | 0.58% |
| BBH | 44.47% | $397.87M | 0.35% |
| GNOM | 43.08% | $70.59M | 0.5% |
| PTH | 39.43% | $143.31M | 0.6% |
| FXH | 38.08% | $1.15B | 0.62% |
| VHT | 37.31% | $17.06B | 0.1% |
| FHLC | 36.95% | $2.73B | 0.084% |
| PINK | 36.52% | $161.15M | 0.5% |
| ARKG | 36.30% | $1.13B | 0.75% |
| IYH | 35.52% | $3.19B | 0.39% |
| QQQJ | 33.83% | $698.04M | 0.15% |
| FXD | 33.71% | $1.54B | 0.61% |
| IWP | 33.42% | $17.19B | 0.23% |
| IXJ | 33.35% | $3.89B | 0.41% |
| CRUZ | 33.04% | $24.92M | 0.45% |
| IWO | 32.75% | $12.56B | 0.24% |
| VBK | 32.73% | $19.31B | 0.07% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| KRBN | -0.01% | $242.47M | 0.85% |
| MINT | -0.03% | $11.62B | 0.35% |
| DBB | -0.37% | $126.37M | 0.77% |
| CPER | 0.45% | $159.52M | 0.97% |
| PDBC | -0.63% | $4.40B | 0.59% |
| WEAT | -0.74% | $120.27M | 0.28% |
| DBC | 0.77% | $1.39B | 0.87% |
| HIGH | 0.89% | $302.78M | 0.51% |
| SHV | 0.95% | $18.13B | 0.15% |
| CCOR | -0.99% | $109.04M | 1.18% |
| USCI | 1.07% | $185.47M | 1.07% |
| KCCA | -1.44% | $220.51M | 0.87% |
| TBLL | 1.63% | $1.92B | 0.08% |
| CSHI | -1.92% | $482.85M | 0.38% |
| DUSB | 2.10% | $797.63M | 0.15% |
| ULST | -2.16% | $535.47M | 0.2% |
| AGZD | -2.37% | $142.76M | 0.23% |
| GCC | 2.41% | $133.23M | 0.55% |
| DBMF | -2.72% | $1.02B | 0.85% |
| COMT | -2.94% | $829.06M | 0.48% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -22.89% | $388.04M | 1.43% |
| VIXY | -21.94% | $195.31M | 0.85% |
| TAIL | -13.65% | $67.98M | 0.59% |
| TPMN | -12.92% | $40.60M | 0.65% |
| GBIL | -9.40% | $5.60B | 0.12% |
| FMF | -7.78% | $244.61M | 0.95% |
| CTA | -7.37% | $350.27M | 0.78% |
| KMLM | -7.31% | $353.87M | 0.9% |
| BOXX | -7.00% | $4.43B | 0.1949% |
| USDU | -6.91% | $201.97M | 0.5% |
| XBIL | -6.82% | $637.70M | 0.15% |
| BILZ | -6.17% | $563.02M | 0.14% |
| FLMI | -6.10% | $356.19M | 0.3% |
| DBE | -6.00% | $50.13M | 0.77% |
| DBO | -5.98% | $217.57M | 0.77% |
| DBA | -5.74% | $755.88M | 0.93% |
| UUP | -5.71% | $309.25M | 0.77% |
| XHLF | -4.53% | $874.27M | 0.03% |
| TBIL | -4.22% | $4.38B | 0.15% |
| GSG | -3.43% | $914.42M | 0.75% |
News
Yahoo
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […]
SeekingAlpha
Tweedy Browne's 13F portfolio value drops to $2.10B with reductions in top positions like Berkshire Hathaway and Alphabet. Read an update on the portfolio here.
Yahoo
Ionis Pharmaceuticals (IONS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Yahoo
Ionis Pharmaceuticals ( NASDAQ:IONS ) Third Quarter 2024 Results Key Financial Results Revenue: US$134.0m (down 7.1...
Yahoo
IONS reports better-than-expected top and bottom-line numbers for the third quarter of 2024.
Yahoo
Companies in The News Are: ODP,IONS,JCI,QLYS
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.